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Abstract
Background
Pneumonia is a serious disease associated with mortality among patients with dementia.
However, the reported frequency of pneumonia as a cause of death in patients with demen-
tia varies, the reason for which has not been fully elucidated.
Methods
We conducted a systematic search in PubMed and the Cochrane Database of Systematic
Reviews (inception to December 2016). Two authors independently determined the suitabil-
ity of studies and potential bias and extracted the data. The primary outcome was frequency
of pneumonia-associated death in patients with dementia. Stratified subgroup analysis was
conducted among studies grouped according to type of mortality cause (immediate or
underlying), information source of mortality cause (autopsy or death certificate), and study
setting (clinic, hospital, or nursing home).
Results
We included 7 studies reporting the cause of death among patients with dementia and 12
studies comparing the cause of death among patients with and without dementia. The fre-
quency of pneumonia-associated death among 19 eligible studies was 29.69% (95% confi-
dence interval [CI], 25.86–33.53). Those frequencies differed according to whether the
source for information about cause of death was an autopsy confirmation (49.98%; 95% CI,
43.75–56.71) or death certificate (19.65%; 95% CI, 15.48–23.83) and according to whether
the type of mortality cause was an indirect cause of death (13.96%; 95% CI, 9.42–18.51) or
direct cause of death (44.45%; 95% CI, 29.81–50.10). The risk of pneumonia-associated
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death in patients with dementia was twice as high as among those without dementia (odds
ratio, 2.15; 95% CI, 1.63–2.83; p < 0.001).
Conclusion
The various frequencies of pneumonia-associated death in patients with dementia were
associated with the information source, type of mortality cause, and study setting. Patients
with dementia in the terminal stages urgently require careful clinical management of pneu-
monia, to maximize patient life expectancy and quality.
Introduction
Pneumonia is a primary cause of hospitalization and mortality, especially for older adults
[1,2]. With rapid growth of the older population, the importance of the clinical management
of pneumonia is growing. The aging trend is accompanied by an increasing number of patients
with dementia, which is becoming a major healthcare challenge [3]. Our previous study indi-
cated that dementia was a risk factor for the occurrence of aspiration pneumonia in older
adults [4]. Several studies have also reported that people with dementia tend to die more often
from pneumonia [5–10]. A previous meta-analysis indicated that the odds of pneumonia-asso-
ciated death were increased more than twofold for patients with dementia than for those with-
out dementia [11]. However, the reported frequency of pneumonia-associated death among
older adults with dementia varies, ranging from 12% to 70% [6–13]. Dementia covers a wide
range of symptoms and encompasses a group of related neurodegenerative disorders. The vari-
ous clinical factors relating to pneumonia-associated death are likely to coexist. Therefore, we
hypothesized that the frequency of pneumonia-associated death differ depending on the meth-
ods used to obtain information about the cause of death (autopsy or death certificate), types of
mortality cause (immediate or underlying cause), study settings, and the subtypes of dementia
investigated.
The aims of the present study were to elucidate the frequency of pneumonia-associated
death in older adults with dementia and how the frequency of pneumonia-associated death
differ according to the data on cause of death (autopsy or death certificate). The results can
contribute to the clinical management of patients with dementia in preventing pneumonia, to
maximize life expectancy in these patients.
Methods
This systematic review and meta-analysis was conducted according to the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and the statement by
the Meta-analysis of Observational Studies in Epidemiology (MOOSE) group [14, 15]. A pre-
defined protocol was not registered. Institutional review board approval and patient consent
were not required because of the review nature of this study.
Search strategy
Two investigators (TM and YF) independently searched for eligible studies in PubMed and
the Cochrane Database of Systematic Reviews, published from database inception to Decem-
ber 2016. We used the following key words: “(dementia OR Alzheimer’s dementia OR Alzhei-
mer’s disease OR Alzheimer disease OR dementia with Lewy bodies OR diffuse Lewy body
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disease OR vascular dementia OR frontotemporal dementia OR mixed-type of dementia)
AND (pneumonia OR lower respiratory tract infection OR bronchopneumonia OR aspiration
pneumonia OR nosocomial pneumonia OR community-acquired pneumonia OR hospital-
acquired pneumonia OR nursing and healthcare-associated pneumonia OR ventilator-associ-
ated pneumonia) AND (mortality OR death OR comorbidity)”. The search was limited to
studies written in English. The detailed search strategy is available in the supplementary
appendix (S1 File). We also reviewed the reference lists of eligible studies using Google Scholar
and performed a manual search to ensure that all appropriate studies were included.
Eligibility criteria and outcome measures
Studies fulfilling the following selection criteria were included in the meta-analysis: (1) study
design and language: randomized controlled trials, cohort studies, cross-sectional studies, and
case series in English language; (2) population: adult patients with dementia or without
dementia (as control patients); (3) primary outcome variables: the distributions of pneumo-
nia-associated death. In the secondary outcome; (4) secondary outcome: the effect size on the
odds ratio (OR) for pneumonia-associated mortality in patients with dementia was compared
with patients without dementia. Studies were excluded based on the following criteria: (1)
studies that only had abstracts; (2) studies where the outcome variable was not reported; and
(3) studies that presented only an approximate frequency of pneumonia-associated death with-
out the exact number of patients.
We conducted subgroup analysis among studies grouped according to the source of infor-
mation about the cause of death, type of mortality cause, and study setting, to investigate pneu-
monia-associated death.
Data extraction
Two reviewers extracted the data independently. Articles retrieved in the search were stored in
a citation manager (EndNote X7; Thomson Reuters, New York, NY, USA). After removing
redundant articles, titles and abstracts and then full-text articles were investigated. We
extracted the following data: study design, study period, study site, study setting (clinic, hospi-
tal, or nursing home), inclusion/exclusion criteria of each study, information source of the
cause of death (autopsy or death certificate), type of mortality cause (immediate or underly-
ing), general patient background, and dementia type. Outcome variables were extracted into
predesigned data collection forms. We verified data accuracy by comparing the collection
forms of each investigator; any discrepancies were resolved through discussion together with
three other authors (KM, HA and KK).
In previous meta-analyses, the underlying cause of death was defined as the disease, injury,
or corresponding circumstance that initiated the chain of events (i.e., the intermediate cause of
death) ultimately leading to death (7, 8, 9). The immediate cause of death was defined as the
final disease, injury, or complication directly causing death (7, 8, 9).
Data analysis
Throughout the meta-analysis, we calculated the prevalence of pneumonia-associated death or
ORs with 95% confidence interval (CIs) using a random effects model, generic inverse vari-
ance method. To assess the prevalence of pneumonia-associated mortality among patients
with dementia, the standard error was calculated using the Agresti–Coull method [16]. Het-
erogeneity among the original studies was evaluated using I2 statistics and classified as no het-
erogeneity (I2 = 0), low (� 25%), medium (25%–50%), and high (� 75%) [17]. Publication
bias was examined using a funnel plot. For all analyses, significance levels were two-tailed, and
Pneumonia-associated death in dementia
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p< 0.05 was considered significant. All statistical tests were performed using Review Manager
(RevMan) ver. 5.3.5 (Cochrane Collaboration, Copenhagen, Denmark) [18].
Results
Study selection and characteristics
Of the 607 references screened, 7 studies [6, 9, 12, 19–22] reported the cause of death among
patients with dementia; 12 studies [7, 8, 10, 13, 23–30] identified pneumonia-associated death
in comparative studies reporting the cause of death among patients with dementia versus
those without dementia (Fig 1).
In a total of 19 studies, the distribution of pneumonia-associated death was analysed in
79,956 patients with dementia. Among the 19 studies, autopsy-confirmed cause of death was
used in all hospital-based studies [6, 8–10, 12, 19, 26] except one [27]; 8 population-based stud-
ies [7, 13, 22, 23, 25, 28–30], 2 studies in nursing homes [20, 21] and 1 study in a clinic [24]
used death certificates as the source for cause of death (Table 1). In the 12 comparative studies,
40,039 patients with dementia and 332,456 without dementia were compared for pneumonia-
associated death. The most common type of dementia was Alzheimer disease (AD) and four
studies included only patients with AD [19, 21, 24, 29].
Prevalence of pneumonia-associated death among patients with dementia
In all 19 studies, we identified 79,956 patients with dementia and estimated the prevalence of
pneumonia-associated death. The result indicated that 29.69% (95% CI, 25.86–33.53; I2 = 99%;
p for heterogeneity < 0.001) of patients with dementia died owing to pneumonia (Fig 2).
In the subgroup analysis according to information source for the cause of death (autopsy or
death certificate), the estimated frequency of pneumonia-associated death in studies using
autopsy confirmation was 49.98% (95% CI, 43.75–56.21; I2 = 72%; p for heterogeneity = 0.002)
(Fig 3A) whereas that in studies using death certificates was 19.65% (95% CI, 15.48–23.82; I2 =
99%; p for heterogeneity < 0.001) (Fig 3B).
In the second subgroup analysis according to type of mortality cause (immediate or under-
lying), the estimated frequency of pneumonia-associated death as immediate cause was
44.45% (95% CI, 29.81–59.10; I2 = 91%; p for heterogeneity < 0.001) (Fig 4A) whereas the esti-
mated frequency of those as underlying cause was 13.51% (95% CI, 9.42–18.51; I2 = 91%; p for
heterogeneity < 0.001) (Fig 4B).
In the final subgroup analysis according to study setting (clinic, hospital, or nursing home),
the frequency of pneumonia-associated death in hospital-based studies was the same as that in
studies using autopsy confirmation (Figs 3A and 5A) and higher than the frequency in nursing
home-based studies (20.76%; 95% CI, 8.35–33.18; I2 = 79%; p for heterogeneity = 0.001) (Fig
5B) and population-based studies (19.50%; 95% CI, 14.50–24.49; I2 = 100%; p for
heterogeneity < 0.001) (Fig 5C).
Risk of pneumonia as a cause of death in patients with and without dementia
Among the 12 comparison studies that reported pneumonia-associated death among patients
with dementia versus those without dementia, cumulative analysis showed a significant risk of
pneumonia as a cause of death in patients with dementia, as compared with those who did not
have dementia (OR, 2.15; 95% CI, 1.63–2.83; p< 0.001) (Fig 6A). However, the results among
studies of autopsy-confirmed patients were higher (OR, 2.70; 95% CI, 1.07–6.80; p = 0.03) (Fig
6B) than those of studies that obtained the cause of death from a death certificate (OR, 2.01;
95% CI, 1.50–2.70; p< 0.001) (Fig 6C).
Pneumonia-associated death in dementia
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Discussion
The present systematic review and meta-analysis revealed that the frequency of pneumonia-
associated death in patients with dementia varied according to the information source, type of
mortality cause, and study setting. The frequency of pneumonia-associated death in patients
with dementia was 49.98% if the source of information for cause of death was autopsy confir-
mation. This frequency was 2.5 times higher than that in studies using a death certificate
Fig 1. Systematic review flow diagram. n is the number of articles.
https://doi.org/10.1371/journal.pone.0213825.g001
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Table 1. Baseline characteristics of included studies comparing pneumonia-associated mortality in patients with and without dementia.
Study, year of
publication
country Study setting Study design Resource that
provided
information for
cause of death
Cause of death;
(underlying or
immediate)
Sample
size
Mean age–yr
±SD
Gender–
Female, n
(%)
Types of
dementia among
patients with
dementia- (%)
Study examining
cause of death on
dementia
Burns, 1990 [19] UK Hospital longitudinal Autopsy and death
certificate
- 53 80.4 (range,
56–99)
79 AD (100.0)
Fu, 2004 [6] USA Hospital retrospective Autopsy - 52 77.6 ± 10.8 48.1 AD (55.8), AD
and DLBD (3.8),
FTD (9.4), VaD
(5.7)
Wachterman, 2008
[20]
USA Nursing home cohort Death certificate immediate 165 86.5 ± 7.2 End-stage
dementia
Brunnstrom, 2009
[9]
Sweden Hospital retrospective Autopsy underlying &
immediate
524 78.6 ± 9.1 55.3 AD (42), VaD
(23.7), AD and
VaD (21.6)
Bosek, 2013 [21] USA Nursing home retrospective Clinical diagnosis 57 - AD (100)
Manabe, 2015 [12] Japan Hospital retrospective Autopsy immediate 157 84.5 ± 8.5 61.3 AD (40.1), DLB
(26.8), VaD
(33.1)
Vorst,2016 [22] Netherlands Population
based (day
clinic or
inpatient)
cohort Death certificate underlying 39164 81.4 ± 7.0 61.3 AD (62.4), VaD
(12.5), Others
(25.1)
Comparative study
on patients with
versus without
dementia
Kukull, 1994 [7] USA Population retrospective Death certificate underlying 87 vs. 17 82.5 ± 5.0
(probable
AD)
54.0 AD (11.5),
probable AD
(63.2), others
(25.3)
Morgan and Clarke,
1995 [23]
UK Population prospective
cohort
Death certificate principal 64 vs.
448
�75 y,
82.9%
65.7 -
Beard, 1996 [24] USA clinic case-control Death certificate underlying &
immediate
917 vs.
703
- - AD (100)
Kammoun, 2000 [8] Switzerland Hospital retrospective Autopsy immediate 120 vs.
222
85.0 ± 6.9 AD (76.7), VaD
15.5), MTD
(9.6), others
Tschanz, 2004 [25] Sweden Population county study Death certificate - 291 vs.
947
83.3 ± 7.0 64.0 AD (57.7), VaD
(15.5), MTD
(9.6), others
Attems, 2005 [26] Austria Hospital retrospective Autopsy - 176 vs.
132
83.5 ± 8.6 58.1 AD, VaD, MTD,
others
Laditka, 2005 [27] USA Hospital retrospective Death certificate - 36887 vs.
327425
- - -
Chamandy and
Wolfson, 2005 [28]
Canada Population cohort Death certificate underlying 754 vs.
618
87.6 ± 7.26 68.2 AD, VaD, MTD,
others
Ganguli, 2005 [29] USA population cohort Death certificate underlying 236 vs.
546
73.4 ± 5.9 57.8 AD (100)
Andersen, 2010 [30] Denmark Population cohort Death certificate 286 vs.
884
81.2 ± 3.8 64.3 AD (67.4)VaD
(19.1), MTD and
others,
Todd, 2013 [13] USA Population cohort Death certificate underlying 85 vs. 52 78.6 ± 7.5 68.3 -
(Continued)
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(19.65%) as well as nursing home-based (20.76%) and population-based (19.50%) studies. The
frequency of pneumonia as an immediate cause of death (44.45%) was three times higher than
as an underlying cause of death (13.51%). Patients with dementia had a two-times greater risk
of death owing to pneumonia compared with patients who did not have dementia.
With rapid growth of the older population, pneumonia has become one of the most impor-
tant infectious diseases in terms of frequency, disease prognosis, and impact on society. Older
adults with dementia in particular are more likely to die from pneumonia than those without
dementia [6–9, 11]. Although the number of older adults facing dementia has been increasing
globally, the current situation is that the clinical evidence for managing patients with dementia
remains insufficient. Therefore, we could only evaluate 19 studies in the present study, to con-
firm the risk of pneumonia-associated death among older adults with dementia. Our results
indicated the risk of pneumonia-associated death was increased more than twofold in patients
with dementia (OR, 2.15) (Fig 6). These results indicated that patients with dementia may have
weaker defence mechanisms for overcoming respiratory tract infections than those without
dementia. Previous studies have revealed an association between respiratory function and
Table 1. (Continued)
Study, year of
publication
country Study setting Study design Resource that
provided
information for
cause of death
Cause of death;
(underlying or
immediate)
Sample
size
Mean age–yr
±SD
Gender–
Female, n
(%)
Types of
dementia among
patients with
dementia- (%)
Magaki, 2014 [10] USA Hospital retrospective Autopsy immediate 45 vs.
124
78.5 ± 11.5 47.7 AD (80.3), FTD
(6.4), DLBD
(3.2), others
Abbreviations: AD, Alzheimer disease; DLBD, diffuse Lewy body disease; FTD, frontotemporal dementia; VaD, vascular dementia, MTD, mixed-type dementia. Sample
size among comparative studies presented as patients with versus patients without dementia.
https://doi.org/10.1371/journal.pone.0213825.t001
Fig 2. Meta-analysis for frequencies of pneumonia-associated death in patients with dementia. Data for all 19 studies on patients with dementia.
Cumulative meta-analysis using a random effects model for frequency of pneumonia-associated death is shown, by study. Squares represent 95% confidence
intervals (CIs). Diamonds at the bottom of the figure show 95% CI range of the overall estimates.
https://doi.org/10.1371/journal.pone.0213825.g002
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cognition, which is impaired in dementia [31–33]. The deterioration of respiratory function
may also influence the reduced lifespan once patients with dementia develop pneumonia.
However, the reported frequency of pneumonia-associated death varies among patients with
dementia [6–13]. In addition, the ORs of pneumonia-associated death differed according to
whether the source of information about the cause of death was a death certificate or an
autopsy report (Fig 6B and 6C). It is important to investigate these differences in frequency of
pneumonia-associated deaths in daily clinical practice for patients with dementia, among
which the number of such deaths is increasing rapidly, with the global aging population.
Among all eligible studies including patients with dementia, the frequency of pneumonia as
a cause of death was approximately 20% in studies using death certificates (Fig 3C); however,
this frequency was approximately 50% in studies using autopsy reports in hospital settings (Fig
3B). This high frequency of pneumonia cause of death in patients with dementia among stud-
ies using death certificates was similar to the pneumonia-associated deaths in studies reporting
an immediate cause of death (Fig 4A) as well as in population-based (Fig 5C) and nursing
home-based (Fig 5B) studies. Although comorbid conditions among patients in the present
Fig 3. Meta-analysis for frequencies of pneumonia-associated death in patients with dementia according, to information source for the cause of death.
(a) Data from 7 studies using autopsy reports. (b) Data from 12 studies using death certificates. Cumulative meta-analysis using a random effects model for
frequency of pneumonia-associated death is shown, by study. Squares represent 95% confidence intervals (CIs). Diamonds at the bottom of the figure show
95% CI range of the overall estimates.
https://doi.org/10.1371/journal.pone.0213825.g003
Pneumonia-associated death in dementia
PLOS ONE | https://doi.org/10.1371/journal.pone.0213825 March 14, 2019 8 / 14
study could not be examined, our results suggest that pneumonia has a strong and direct
impact on mortality in older adults with dementia, regardless of whether they have other, pos-
sibly fatal underlying conditions. In fact, studies using autopsy reports presented the immedi-
ate cause of death, which is defined as the final disease, injury, or complication directly
causing death [9]. However, studies using a death certificate presented the underlying cause of
death, which is the disease, injury, or corresponding circumstance that initiated a chain of
events ultimately leading to death [9]. In our previous study, pneumonia-associated deaths
among patients with dementia accounted for 35.0% to 44.6% of deaths in all patients, for the
underlying and immediate causes of death, respectively [12]. The clinical diagnosis of pneu-
monia in older adults is difficult and often delayed because of atypical or paucisymptomatic
presentations including the absence of fever, paucity or absence of cough, changes in mental
status (delirium), and poorly contributive physical examination [1, 34]. Silent pneumonia may
have a greater impact as the direct cause of death than clinical presentation among older
adults, especially those with advanced stages of dementia in the hospital setting. The important
physical changes associated with aging include decreases in the elastic recoil of the lungs, com-
pliance of the chest wall, and strength of the respiratory muscles [24]. Parkinsonism during
the course of Alzheimer’s disease (AD) [35] and sequelae of cerebral vascular disease also con-
tribute to decreasing respiratory muscle function [36, 37]. A previous study suggested that
weakness of the extremities in patients with dementia with Lewy bodies (DLB) may be associ-
ated with low respiratory function [38]. Thus, such decreased respiratory functions have
important consequences on the functional reserve of older adults with dementia, leading to a
further decreased ability to cope with reduced lung compliance and increased airway resis-
tance. Therefore, once these patients develop a lower respiratory tract infection, they can easily
develop recurrent pneumonia, which can lead to pneumonia-caused mortality.
Fig 4. Meta-analysis for frequencies of pneumonia-associated death in patients with dementia, according to type of mortality cause. (a) Data from four
studies that reported pneumonia as an immediate cause of death. (b) Data from five studies that reported pneumonia as a underlying cause of death.
Cumulative meta-analysis using a random effects model for frequency of pneumonia-associated death is shown, by study. Squares represent 95% confidence
intervals (CIs). Diamonds at the bottom of the figure show 95% CI range of the overall estimates.
https://doi.org/10.1371/journal.pone.0213825.g004
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Although we were unable to evaluate the status of dysphagia among patients in the present
study, most were in the terminal stage of illness and their cognitive impairments might have
been severe. One study reported that patients with dementia (mean age 86 years) inevitably
develop dysphagia and have a high risk of aspiration pneumonia, which is related to hospital-
based mortality [39]. A previous meta-analysis suggested that the prevalence of swallowing dif-
ficulties ranges from 13% to 57% in different types of dementia, and the prevalence of swallow-
ing difficulties in patients with DLB is higher than in those with AD. Owing to limited data
availability for the present meta-analysis, the most common form of dementia among the
included patients was AD (Table 1). Although we were unable to conduct an evaluation
according to the different forms of dementia, dysphagia, which may lead to the development
of fatal pneumonia, may differ in different forms of dementia associated with lesions in diffuse
areas of the brain, which result in disorders of cognition and deterioration in oral, pharyngeal,
and laryngeal functioning [40]. Further studies are needed to clarify this question.
The present meta-analysis was limited to the evaluation of published data. The eligible stud-
ies in this meta-analysis included population-based studies and hospital, clinic, and nursing
Fig 5. Meta-analysis for frequencies of pneumonia-associated death in patients with dementia according to study settings. (a) Data of seven hospital-based
studies. (b) Data of two nursing home-based studies. (c) Data of eight population-based studies. Cumulative meta-analysis using a random effects model for
frequency of pneumonia-associated death is shown, by study. Squares represent 95% confidence intervals (CIs). Diamonds at the bottom of the figure show
95% CI range of the overall estimates.
https://doi.org/10.1371/journal.pone.0213825.g005
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home-based studies. The various study settings, general clinical conditions, comorbidities, and
disease severity among patients in the present study varied widely. However, dementia covers
a wide range of symptoms and encompasses a group of related neurodegenerative disorders.
As the nature of disease among study participants as well as the nature of meta-analysis pre-
cludes the use of individual patient data, the heterogeneity among patients in each study could
not be determined. There was also the possibility of different criteria used to determine pneu-
monia as the cause of death among studies. The present study findings warrant the further
Fig 6. Risk of pneumonia-associated mortality in patients with and without dementia. (a) Data for 12 studies that compared patients with versus those
without dementia. (b) Data from 3 studies that examined pneumonia-associated death using autopsy reports. (c) Data from 9 studies that examined
pneumonia-associated death using death certificates. Cumulative meta-analysis using a random effects model with odds ratios (ORs) shown by study. Squares
represent 95% confidence intervals (CIs). Diamonds at the bottom of the figure show 95% CI range of the overall estimates.
https://doi.org/10.1371/journal.pone.0213825.g006
Pneumonia-associated death in dementia
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investigation among patients with the same subtypes of dementia as well as the same underly-
ing clinical conditions.
Conclusion
We found that approximately 50% of patients with dementia in the hospital setting died owing
pneumonia, according to cause of death confirmed by autopsy. This frequency may be much
higher than clinician’s expectations. Our results indicated that clinicians must pay careful
attention in cases of pneumonia among patients with dementia in the terminal stages of illness,
to maximize patients’ life expectancy and quality.
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